for the DIGITAT Study Group OBJECTIVE: The Disproportionate Intrauterine Growth Intervention Trial at Term (DIGITAT) compared induction of labor and expectant management in suspected intrauterine growth restriction (IUGR) at term. In this subanalysis, we report neonatal morbidity between the policies based on the Morbidity Assessment Index for Newborns (MAIN).
I
ntrauterine growth restriction (IUGR) is defined as an estimated fetal weight or an abdominal circumference below the 10th centile for gestational age. 1 Postnatally, children with a birthweight below the 10th centile are classified as small for gestational age (SGA). The latter condition is identified only after birth. However, IUGR [2] [3] [4] [5] and SGA [6] [7] [8] [9] [10] [11] [12] [13] are associated with perinatal morbidity and mortality, even at term. There is no consensus on the management of pregnancies complicated by IUGR. [14] [15] [16] We recently performed the Disproportionate Intrauterine Growth Intervention Trial at Term (DIGITAT) 17 to investigate whether induction of labor for pregnancies with suspected IUGR beyond 36 weeks' gestation reduced neonatal morbidity and mortality compared with an expectant approach with fetal and maternal surveillance. Unlike many retrospective studies on growth restriction, our study did not look retrospectively at children being born SGA but followed up children prospectively with suspected IUGR at term.
The study showed comparable primary fetal outcomes (a composite of perinatal death, 5 minute Apgar score below 7, umbilical arterial pH below 7.05, or admission to neonatal intensive care unit [NICU] ) as well as comparable rates of operative deliveries. Although the total number of children admitted to the intensive care unit did not differ between the groups, more children in the induction group were admitted to an intermediate level of care than in the expectant group (48% vs 36%; difference, 12%; 95% confidence interval [CI], 5-20%).
Complications of late prematurity 13, 18, 19 might explain this because children in the induction group were born on average 10 days earlier than in the expectant group, (266 days vs 277 days; difference, -9.9 days; 95% CI, -11 to -9). 17 However, the difference may simply reflect policies for admission to intermediate levels of care related to prematurity rather than clinically relevant morbidity.
It is important to resolve these 2 competing explanations because in the expectant group, more children were severely growth restricted, defined as a birthweight below the third percentile (13% vs 31%: difference, -18%; 95% CI, -24% to -12%) and therefore had a possible higher risk of neonatal morbidity. [2] [3] [4] [6] [7] [8] [9] [10] [11] [12] To study the net influence of the 2 policies on neonatal morbidity in detail, the Morbidity Assessment Index for Newborns (MAIN) score, a validated outcome measure for neonatal morbidity, was calculated and compared. 20, 21 
MATERIALS AND METHODS
This is a secondary analysis of the DIGI-TAT. The original trial was approved by the University of Leiden Institutional Review Board (P04.210). Written informed consent was obtained from all participants before randomization.
The study population consisted of children born to mothers who participated in the DIGITAT. Between November 2004 and November 2008, pregnant women with a singleton fetus in cephalic presentation and suspected IUGR between 36 ϩ0 and 41 ϩ0 weeks were recruited. Suspected IUGR was defined as a fetal abdominal circumference or an estimated fetal weight below the 10th percentile or deceleration of the fetal abdominal circumference in the third trimester. 20 Exclusion criteria were previous cesarean section, diabetes mellitus, or gestational diabetes requiring insulin therapy, renal failure, human immunodeficiency virus seropositivity, prelabor rupture of membranes, severe preeclampsia, HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), or a fetus with aneuploidy or congenital abnormalities suspected on ultrasound. Fetuses with decreased or absent movements, and those with abnormal heart rate tracings, were also excluded.
Consenting women were randomly allocated to either induction or expectant monitoring. Participants allocated to the expectant monitoring group were monitored until the onset of spontaneous labor with daily fetal movement counts and twice-weekly heart rate tracings, ultrasound examination, maternal blood pressure measurement, assessment of proteinuria, laboratory tests of liver and kidney function, and full blood count. Women were monitored as either an outpatient or an inpatient, according to local protocol. In the expectant monitoring group, induction of labor or planned cesarean section was performed for obstetrical indications, such as suboptimal fetal heart rate tracings, prolonged rupture of membranes, or postmaturity between T plus 7 and T plus 14 days, at the obstetrician's discretion.
Morbidity was calculated using the MAIN score. 20, 21 This score was developed to provide a numeric index of early neonatal outcomes of prenatal care and adverse prenatal exposures in babies delivered beyond 28 weeks of gestation. It is a sensitive and discriminative outcome measure for obstetric clinical trials and is particularly suited for studies with outcomes other than extreme preterm delivery. The data items, such as Apgar scores at 5 and 10 minutes, cord blood pH, hyperbilirubinemia, hypoglycemia, intraventricular hemorrhage, and the need for intubation, can all be obtained from the hospital discharge summaries. The final score is divided into 4 morbidity categories: below 150 (no/minimal morbidity), 151-500 (mild morbidity), 501-800 (moderate morbidity), and more than 800 (severe morbidity). 21 A MAIN score greater than zero is considered as a positive MAIN score. For children admitted to the NICU or intermediate level care, items for the MAIN score were obtained from the discharge summaries. For those discharged home immediately after birth or admitted only to the maternal ward, no separate discharge summaries are written, so for them 5 and 10 minute Apgar scores and arterial umbilical artery pH only were used, assuming that the other items, if not reported, were normal.
Data were analyzed according to intention to treat. Continuous variables were compared using a Student t test or Fisher exact test when data were normally distributed or the nonparametric Mann-Whitney U test for skewed data. . BMI, body mass index; CI, confidence interval. a n ϭ 275 for induction; n ϭ 295 for expectant monitoring; b n ϭ 294 for induction; n ϭ 311 for expectant monitoring; c n ϭ 304 for induction; n ϭ 312 for expectant monitoring; d P Ͻ .001; e P Ͻ .05.
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We studied the effect of gestational age at randomization on different outcome parameters, such as mean MAIN score, severe MAIN score, and composite adverse neonatal outcome. This was done using generalized additive logistic regression models in which the effect of gestational age is estimated with a smoothed curve. 22 We tested for differences between the 2 groups using likelihood ratio tests.
RESULTS
In the DIGITAT trial, 321 women were randomized for induction and 329 for an expectant management policy ( Figure   1 ). The MAIN score was assessed in 308 induction group babies and in 315 expectant management group babies. Baseline characteristics and main trial results are displayed in Table 1 . There were no differences between the randomized groups in maternal comorbidities such as preeclampsia or gestational hypertension, heart and vascular disorders, or autoimmune disease (data not shown).
As a result of deferring delivery for 10 days with expectant management, gestational age and birthweight differed significantly between the 2 groups. More babies were admitted to the intermediate level of care after induction. No other differences at baseline were found.
Most women who were randomized met either the fetal abdominal circumference below the 10th centile or the estimated fetal weight below the 10th centile criterion (Table 1 ). Only 13 women in the induction group and 10 in the expectant monitoring group were included because of flattening of the fetal abdominal circumference growth curve only.
The categories of the MAIN scores (no/minimal, mild, moderate, and severe morbidity) did not differ between the induction and expectant group. When we looked at components of the MAIN score, more children suffered from hyperbilirubinemia greater than 220 mmol/L or the need for phototherapy after induction of labor (Table 2) . In Table 2 , composite neonatal morbidity (CNM) is shown. When we stratified for different admission types (NICU, intermediate level care, ward), we also found comparable MAIN scores (Table 3) . Stratification for different weight per- ............................................................................................................................................................................................................................................................................................................................................................... 
www.AJOG.org
Obstetrics Research centiles showed no differences between the MAIN score (Table 3) . Five children were admitted to intensive care with a MAIN score of zero. Figure 2 shows the percentage of neonatal admissions related to gestational age at randomization for both groups. Gestational age had a significant effect on the risk of being admitted to neonatal care (NICU and intermediate level care), with a higher risk at a lower gestational age. The percentage of children admitted to neonatal care was lower after an expectant management.
We also compared the percentage of babies born after induction of labor with a positive MAIN score with babies born after an expectant management. Although we found fewer babies with a positive MAIN score beyond 38 weeks' randomization as compared with randomization at 36 or 37 weeks, the percentages in the 2 groups were comparable ( Figure 3) .
In Figure 4 , we compared the primary outcome of the trial (composite adverse neonatal outcome; perinatal death, arterial umbilical artery pH below 7.05; 5 minute Apgar below 7; or admission to the NICU) in relation to gestational age at randomization. In both the induction group as well as in babies born after expectant management, at the different gestational ages, comparable percentages of composite adverse outcome were found.
For all 3 outcomes (neonatal admissions, positive MAIN score, and composite adverse outcome), we compared induction vs expectant management in women randomized before 38 weeks, from 38 to 40 weeks and after 40 weeks. The only difference was a higher percentage of neonatal admissions after induction before 38 weeks' gestational age; 125 (61%) admissions vs 92 (44%) after expectant management, difference, 16% (95% CI, 6.7-26%; P ϭ .001).
COMMENT
This study confirmed findings of the DIGITAT, in which no significant differences in neonatal morbidity between induction and expectant management were found. This supports the hypothesis that the higher rate of admissions after induction of labor was a regular caredriven effect of a lower gestational age and lower birthweight, rather than because of defined complications.
Our study was limited to babies suspected of growth restriction at term, 
